In COVID-19, adding lopinavir-ritonavir to usual care did not shorten time to clinical improvement
- PMID: 32539520
- DOI: 10.7326/ACPJ202006160-063
In COVID-19, adding lopinavir-ritonavir to usual care did not shorten time to clinical improvement
Abstract
Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382:1787-99. 32187464.
Comment on
-
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18. N Engl J Med. 2020. PMID: 32187464 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical